FKBP51 and FKBP12.6—Novel and tight interactors of Glomulin

Physiological functions of FBW7 in cancer and metabolism

(2018) Kouhei Shimizu et al.   CELLULAR SIGNALLING

Chemogenomic Profiling of Human and Microbial FK506-Binding Proteins

(2018) Sebastian Pomplun et al.   JOURNAL OF MEDICINAL CHEMISTRY

FKBP Ligands—Where We Are and Where to Go?

(2018) Jürgen M. Kolos et al.   Frontiers in Pharmacology

Novel roles of FKBP5 in muscle alteration induced by gravity change in mice

(2016) Takeshi Shimoide et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Rapid, Structure-Based Exploration of Pipecolic Acid Amides as Novel Selective Antagonists of the FK506-Binding Protein 51

(2016) Steffen Gaali et al.   JOURNAL OF MEDICINAL CHEMISTRY

Structure–Affinity Relationship Analysis of Selective FKBP51 Ligands

(2015) Xixi Feng et al.   JOURNAL OF MEDICINAL CHEMISTRY

Pharmacological Inhibition of the Psychiatric Risk Factor FKBP51 Has Anxiolytic Properties

(2015) J. Hartmann et al.   JOURNAL OF NEUROSCIENCE

Therapeutic Targeting of the FKBP52 Co-Chaperone in Steroid Hormone Receptor-Regulated Physiology and Disease

(2015) Naihsuan C. Guy et al.   Current Molecular Pharmacology

Rational Design and Asymmetric Synthesis of Potent and Neurotrophic Ligands for FK506-Binding Proteins (FKBPs)

(2014) Sebastian Pomplun et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

A Quantitative Chaperone Interaction Network Reveals the Architecture of Cellular Protein Homeostasis Pathways

(2014) Mikko Taipale et al.   CELL

FKBP5 expression in human adipose tissue increases following dexamethasone exposure and is associated with insulin resistance

(2014) Maria J. Pereira et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Selective inhibitors of the FK506-binding protein 51 by induced fit

(2014) Steffen Gaali et al.   Nature Chemical Biology

Stereoselective Construction of the 5-Hydroxy Diazabicyclo[4.3.1]decane-2-one Scaffold, a Privileged Motif for FK506-Binding Proteins

(2014) Matthias Bischoff et al.   ORGANIC LETTERS

ShigellaIpaH7.8 E3 ubiquitin ligase targets glomulin and activates inflammasomes to demolish macrophages

(2014) Shiho Suzuki et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Increasing the Efficiency of Ligands for FK506-Binding Protein 51 by Conformational Control

(2013) Yansong Wang et al.   JOURNAL OF MEDICINAL CHEMISTRY

Crystal Structures of the Free and Ligand-Bound FK1–FK2 Domain Segment of FKBP52 Reveal a Flexible Inter-Domain Hinge

(2013) Andreas Bracher et al.   JOURNAL OF MOLECULAR BIOLOGY

Large FK506-Binding Proteins Shape the Pharmacology of Rapamycin

(2013) A. M. Marz et al.   MOLECULAR AND CELLULAR BIOLOGY

InterAKTions with FKBPs - Mutational and Pharmacological Exploration

(2013) Anne-Katrin Fabian et al.   PLoS One

Exploration of Pipecolate Sulfonamides as Binders of the FK506-Binding Proteins 51 and 52

(2012) Ranganath Gopalakrishnan et al.   JOURNAL OF MEDICINAL CHEMISTRY

Evaluation of Synthetic FK506 Analogues as Ligands for the FK506-Binding Proteins 51 and 52

(2012) Ranganath Gopalakrishnan et al.   JOURNAL OF MEDICINAL CHEMISTRY

Structure of a Glomulin-RBX1-CUL1 Complex: Inhibition of a RING E3 Ligase through Masking of Its E2-Binding Surface

(2012) David M. Duda et al.   MOLECULAR CELL

The Glomuvenous Malformation Protein Glomulin Binds Rbx1 and Regulates Cullin RING Ligase-Mediated Turnover of Fbw7

(2012) Adriana E. Tron et al.   MOLECULAR CELL

Structural characterization of the PPIase domain of FKBP51, a cochaperone of human Hsp90

(2011) Andreas Bracher et al.   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

Fluorescent Probes to Characterise FK506-Binding Proteins

(2009) Christian Kozany et al.   CHEMBIOCHEM

Peptidyl-Prolyl Isomerase FKBP52 Controls Chemotropic Guidance of Neuronal Growth Cones via Regulation of TRPC1 Channel Opening

(2009) Sangwoo Shim et al.   NEURON